MYC and neoplasm: Furthermore, ccRCC1 (“c-myc up”) and ccRCC4 (“c-myc-up and immune up”) are characterised by low tumour cell differentiation, the absence of the tumour suppressor gene BAP1, diminished expression of pro-angiogenic genes, and PDL-1 overexpression.